Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

23,745 total articles

Visa and TIFF Renew Partnership, Bringing Fans Even Closer to the Films, Talent and Festival Experiences They Love

Visa and TIFF Renew Partnership, Bringing Fans Even Closer to the Films, Talent and Festival Experiences They Love

Visa Canada and the Toronto International Film Festival (TIFF) have renewed their partnership for multiple years, marking nearly 30 years of collaboration. The partnership aims to deepen audience access to films and festival experiences, support local businesses and tourism, and promote inclusivity through community programs. Visa will continue off…

QNB Corp. Announces the Execution of a Strategic Repositioning

QNB Corp. Announces the Execution of a Strategic Repositioning

QNB Corp., the parent company of QNB Bank, executed a strategic repositioning by selling a significant portion of low-yielding available-for-sale securities and unwinding pay-fixed swaps, incurring a net pre-tax loss of approximately $26.2 million. The proceeds are reinvested in higher-yielding, low-risk securities and funding loan growth, expected…

Eupraxia Pharmaceuticals Completes Transfer to the Nasdaq Global Select Market and Announces Participation in Upcoming Investor Conferences

Eupraxia Pharmaceuticals Completes Transfer to the Nasdaq Global Select Market and Announces Participation in Upcoming Investor Conferences

Eupraxia Pharmaceuticals Inc., a clinical-stage biotech company focused on targeted drug delivery using its Diffusphere™ technology, has completed its transfer from the Nasdaq Capital Market to the Nasdaq Global Select Market, reflecting compliance with Nasdaq's highest financial and governance standards. The company also announced management's par…

Swvl Expands HSBC Working Capital Facility by 110% to an aggregate of $1.4 million and Deepens Relationship Through HSBC Global Payment Solutions

Swvl Expands HSBC Working Capital Facility by 110% to an aggregate of $1.4 million and Deepens Relationship Through HSBC Global Payment Solutions

Swvl Holdings Corp announced that HSBC increased its working capital facility limit by 110% to $1.4 million, enhancing Swvl’s capacity to fund enterprise contracts and accelerate revenue growth. Concurrently, Swvl adopted HSBC’s global payment solutions in Egypt to streamline high-volume, time-sensitive payments. The expansion aligns with Swvl’s st…

TruGolf Announces Binding Distribution MOU with TruGolf Canada Inc. Covering Defined Canadian and Indigenous Market Opportunities

TruGolf Announces Binding Distribution MOU with TruGolf Canada Inc. Covering Defined Canadian and Indigenous Market Opportunities

TruGolf Holdings, Inc. has entered into a binding Memorandum of Understanding with TruGolf Canada Inc., appointing it as the exclusive master distributor for TruGolf products in Canada and Indigenous markets. The partnership aims to increase availability of TruGolf's golf simulation technology and year-round golf experiences, enhancing market prese…

OFA Group Launches PlanAId, Bringing AI-Assisted Building Code Intelligence Earlier Into the Design Process

OFA Group Launches PlanAId, Bringing AI-Assisted Building Code Intelligence Earlier Into the Design Process

OFA Group (Nasdaq: OFAL) has commercially launched PlanAId, an AI-powered blueprint review platform aimed at helping architects, engineers, and construction professionals identify potential building code issues earlier in the design process. This tool targets reducing project delays by enabling early corrections before formal plan submissions, init…

Top pension funds grow at fastest rate since 2017

Top pension funds grow at fastest rate since 2017

The world's 300 largest pension funds experienced a 13.4% growth in assets under management in 2025, reaching a record $27.7 trillion. Growth was strongest among the top 20 funds, led by the Government Pension Fund of Norway surpassing $2 trillion. Regional shifts show North America leading in asset share but declining slightly, while Asia-Pacific …

Intellia Therapeutics Announces FDA Acceptance of Biologics License Application with Priority Review for Lonvoguran Ziclumeran (Lonvo-z) for Hereditary Angioedema (HAE)

Intellia Therapeutics Announces FDA Acceptance of Biologics License Application with Priority Review for Lonvoguran Ziclumeran (Lonvo-z) for Hereditary Angioedema (HAE)

Intellia Therapeutics announced that the FDA has accepted its Biologics License Application (BLA) for lonvoguran ziclumeran (lonvo-z), the world's first in vivo CRISPR-based therapy and a potential one-time treatment for hereditary angioedema (HAE). The FDA has granted Priority Review with a PDUFA date of March 10, 2027, signaling a potentially exp…

Structure Therapeutics Reports Positive Clinical Data Across Oral Small Molecule Amylin and GLP-1 Programs for Chronic Weight Management

Structure Therapeutics Reports Positive Clinical Data Across Oral Small Molecule Amylin and GLP-1 Programs for Chronic Weight Management

Structure Therapeutics announced positive clinical trial results for two oral small molecule candidates targeting chronic weight management: ACCG-2671 (oral amylin receptor agonist) demonstrated a 6-day half-life and up to 3.3% body weight reduction in Phase 1/2a trial; aleniglipron (oral GLP-1 receptor agonist) showed up to 16.2% mean body weight …

Aduro Clean Technologies to Present Hydrochemolytic™ Technology for Polyolefin Recycling at Chemical Recycling Europe Annual Conference 2026

Aduro Clean Technologies to Present Hydrochemolytic™ Technology for Polyolefin Recycling at Chemical Recycling Europe Annual Conference 2026

Aduro Clean Technologies (NASDAQ: ADUR) announced that Chief Revenue Officer Eric Appelman will present their Hydrochemolytic™ Technology (HCT) for chemical recycling of polyolefins at the Chemical Recycling Europe Annual Conference 2026. Aduro is advancing HCT from pilot-scale validation toward industrial deployment, including a First-of-a-Kind (F…

Rani Therapeutics to Participate in Upcoming September Conferences

Rani Therapeutics to Participate in Upcoming September Conferences

Rani Therapeutics Holdings, a clinical-stage biotherapeutics company focused on oral delivery of biologics, announced that its management team will participate in several investment conferences in September 2026, including the BIG10 Conference and the H.C. Wainwright Global Investment Conference. The company will present its latest developments and…

Avalyn Presents New Data at ERS Congress 2026 Supporting AP01 Lung Distribution and Patient-Centered Trial Design in Pulmonary Fibrosis

Avalyn Presents New Data at ERS Congress 2026 Supporting AP01 Lung Distribution and Patient-Centered Trial Design in Pulmonary Fibrosis

Avalyn Pharma presented new data at the ERS Congress 2026 demonstrating the effective lung distribution of its inhaled antifibrotic therapy AP01 across varying severities of pulmonary fibrosis, supported by in silico modeling. Additionally, patient survey data emphasized the importance of clear communication and reducing logistical burdens to enhan…

Enphase Advances IQ Solid-State Transformer Development for AI Data Centers with Power Modules Now Being Built in Texas

Enphase Advances IQ Solid-State Transformer Development for AI Data Centers with Power Modules Now Being Built in Texas

Enphase Energy announced that its power modules for the IQ Solid-State Transformer, designed specifically for AI data centers requiring 800 VDC power architectures, are now being manufactured in Texas. The modular IQ SST system converts medium-voltage AC to high-voltage DC with rapid response times, aiming to reduce local battery use. The company p…

Spyre Announces Potential Best-in-Class SPY003 (anti-IL-23) Part A Induction Results from SKYLINE Trial, Completing Proof-of-Concept for All Three Components of its IBD Combinations

Spyre Announces Potential Best-in-Class SPY003 (anti-IL-23) Part A Induction Results from SKYLINE Trial, Completing Proof-of-Concept for All Three Components of its IBD Combinations

Spyre Therapeutics announced positive 12-week induction results from Part A of its Phase 2 SKYLINE trial evaluating SPY003, an anti-IL-23 antibody for moderately-to-severely active ulcerative colitis. SPY003 met its primary endpoint with a highly statistically significant reduction in Robart's Histopathology Index score and showed favorable clinica…